ArticleFrontiers in oncology2021

Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma Patients.

Kentaro Ohuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.